Cero Therapeutics Holdings earnings were -$10.5M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest CERO earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$2.1M, down 50% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CERO reported annual earnings of -$10.5M, with 44.3% growth.
Cero Therapeutics Holdings Earnings Reports & History FAQ
What were Cero Therapeutics Holdings's earnings last quarter?
Cero Therapeutics Holdings (NASDAQ: CERO) reported Q4 2024 earnings per share (EPS) of $9.86, up 104.55% year over year. Total CERO earnings for the quarter were -$2.11 million. In the same quarter last year, Cero Therapeutics Holdings's earnings per share (EPS) was -$216.71.
Is Cero Therapeutics Holdings profitable or losing money?
As of the last Cero Therapeutics Holdings earnings report, Cero Therapeutics Holdings is currently losing money. Cero Therapeutics Holdings's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$7.73 million, a 6.07% increase year over year.
What was CERO's earnings growth in the past year?
As of Cero Therapeutics Holdings's earnings date in Q2 2025, Cero Therapeutics Holdings's earnings has grown year over year. CERO earnings in the past year totalled -$10.52 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.